Plain-English translation of NCT07245368 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This study is testing a new medication called to see if it is safe and effective for treating asthma. The trial starts by giving healthy volunteers single or repeated doses of the medication to make sure it is safe, and then moves on to people who actually have mild to moderate asthma. Researchers will carefully watch how your body responds and compare the results between people who receive the medication and those who receive a placebo (a dummy pill).
Asthma is a common condition that affects many people, and researchers are always looking for new and better ways to treat it. This study will help determine whether this medication could become a safe and effective option for people struggling to manage their asthma symptoms.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be randomly assigned to receive either the new medication or a placebo. In Phase 1, healthy volunteers will come in for study visits to receive either a single dose or multiple doses of the treatment over time, with doses gradually increasing. In Phase 2a, people with asthma will receive repeated doses of the medication or placebo and have their safety and response monitored. Throughout the study, you will have regular visits where researchers collect information about how you are doing and how your body is responding to the treatment.
AI-generated summary from trial data · Aug 19, 2026 · Not medical advice
Australia